Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × NSCLC × camrelizumab × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Locally Advanced Gastric Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Esophageal Neoplasms 1 Cervical Cancer Metastatic 1 Advanced Gastric Cancer 1 Advanced Colorectal Carcinoma 1

Interventions

pembrolizumab 1 osimertinib 1 icotinib 1 dacomitinib 1 camrelizumab 1 Radiofrequency Ablation 1 Gefitinib 1 Erlotinib Hydrochloride 1 Bevacizumab 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05547737 2022-09-21

NSCLC

Henan Cancer Hospital

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡